VTRS
Viatris · Healthcare
Smart money activity
Every tracked buy, add, trim, and exit on VTRS by the best portfolio managers in the world. Ranked by manager quality inside each quarter.
Insider activity
SEC Form 4 filings — when CEOs, CFOs, and 10%+ owners buy or sell their own stock.
Latest news
Recent headlines for VTRS.
Hedge funds holding VTRS
1 superinvestor hold Viatris as a top position. Sorted by % of portfolio.
| Manager | % Portfolio |
|---|---|
Generic pharma deep value. | 5.4% |
What will you keep of every $100 in VTRS dividend?
Estimates for educational purposes only. Tax rules change; consult a qualified tax professional for your specific situation. Dividend-tax treatment depends on holding period, account type (taxable vs. retirement), investor type (individual vs. pension vs. mutual fund), limitation-on-benefits tests, and other factors not modeled here.
Get alerts when they buy or sell VTRS
One email per 13F filing — you'll know within hours if any tracked manager moves on VTRS.
Related smart-money signals
Frequently asked questions
Who owns VTRS?
1 tracked superinvestors hold Viatris (VTRS) as a top position based on the latest SEC 13F filings. Largest tracked holder: Seth Klarman at 5.4% of portfolio. Full ranking by % of portfolio shown in the table below.
How many hedge funds hold VTRS?
1 of HoldLens's tracked superinvestors hold VTRS according to the latest SEC 13F filings. The sum of conviction across those holders is 5% (sum of each manager's % of portfolio in VTRS).
Who is the biggest hedge-fund holder of VTRS?
Among HoldLens's tracked superinvestors, Seth Klarman holds the largest VTRS position at 5.4% of portfolio. Generic pharma deep value.
What sector is VTRS?
Viatris (VTRS) is classified as Healthcare. Smart-money activity, insider trades (SEC Form 4), buybacks, short interest, congressional trades, and ETF ownership for VTRS are all aggregated on this page.
Data sourced from SEC 13F filings. VTRS ownership reflects publicly disclosed long positions only. Not investment advice.